Embed Size (px)
DESCRIPTION
Report Scope & Objectives -------------------------- Life science research is weathering an economically challenging time, exacerbated by the federal budget sequestration in the United States and by continued austerity in Europe. Grant money from all sources, both public and private, is increasingly difficult to obtain; and pharmaceutical spending on R&D has flattened following years of solid gains. Adds to this mix a decreased level of reimbursement for molecular diagnostic testing and a slow recovery from the "Great Recession" to establish the external macro economic environment that has led to a new normal that is defined by increasingly constrained budgets. By contrast, developing nations in Asia (China in particular) are making significant investments in higher education, with a focus on science and technology, to include biotechnology. In addition, many global pharmaceutical and biopharmaceutical firms are establishing research centers in these countries; taking advantage of lower cost structures and the new availability of a well-trained work force. Our 2013 studies suggest that average laboratory budgets in Asia are larger than those in the United States and Europe. In this complex macroeconomic environment, life science suppliers are seeking guidance as to how to anticipate market trends in the United States, Europe and Asia in 2014. In this multi-sponsor report, BioInformatics LLC has conducted an in-depth exploration of projected lab budgets and sources of funding by region, and the implications of these findings for the life science tools market in the coming year. The objective of this study is to assess sources of funding, the competitive landscape and market opportunities for life science tools companies. From the perspective of end-users, the goals of this assignment will be to: -Understand current sources of funding from government/stimulus/private foundation grants, distribution time frame and how labs initiate applications for funding. -Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region and market segment; providing directional information for FY2014. -Estimate scientists' budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories. -Assess how optimistic scientists are regarding funding and the future of life science research. To purchase this report, please contact: Angela Fernandez Marketing/Sales Coordinator BioInformatics LLC 703.778.3080 ext. 14 [email protected] www.gene2drug.com
Citation preview
Lab Budgets and Sources of Funding in 2014: The Market Outlook for the United States, Europe and Asia
December 2013
gene2drug.com Life Science Industry Market Research
Life Science Industry Market Research
gene2drug.com
About this Report
•Get an overview of the economic landscape that frames the report
•Learn about the scope of this report and how it will help you with 2014 planning
2
Life Science Industry Market Research
gene2drug.com
About BioInformatics LLC
3
A full-service market research firm since 1994:
• Published and syndicated reports
• Consulting and strategy development
• Expert interviews
• Focus groups
• Surveys
• RateMyProduct™
Life Science Industry Market Research
gene2drug.com
About BioInformatics LLC
Conducting market research exclusively on scientific markets:
• Lab products
• Analytical instrumentation
• Biotechnology research & bioprocessing
• Drug discovery & development
•Molecular diagnostics
4
Life Science Industry Market Research
gene2drug.com
About BioInformatics LLC
5
Project team includes scientists, statisticians and business analysts.
Instant access to a 74,000+ member expert scientific panel.
Conduct market research for major suppliers in the industry.
Life Science Industry Market Research
gene2drug.com
Report Author & Lead Analyst
Robin Rothrock, Ph.D.
Director of Publications
6
Life Science Industry Market Research
gene2drug.com 7
Overview of the Economic Landscape
Life Science Industry Market Research
gene2drug.com 8
Life Science Industry Market Research
gene2drug.com
United States
Sequester
Uncertainty regarding healthcare reform
Changes in molecular diagnostic tests coding and reimbursement
Flat to declining pharmaceutical R&D budgets
9
Life Science Industry Market Research
gene2drug.com
Europe
Continued fiscal austerity
Changes in healthcare institutions and funding
Funding of research is complex and multilayered
Cross-border collaboration is increasing
Leading institutions are taking action to be competitive with the U.S. in recruiting postdocs from India and China
10
Life Science Industry Market Research
gene2drug.com
China
Government and commercial investment: >$260 billion over the next 5 years
• 500 universities
• More than 150,000 life science graduates per year
• Four innovation clusters
• 7,500 life science companies
• 200 life science incubators
• 100 life science parks
11
“Sea turtles” return Growth in pharmaceutical
market
Life Science Industry Market Research
gene2drug.com
A New Normal for Life Science Research
Slow global recovery
Unfavorable research funding
pricing pressure
Growth in Asian markets may be slowing
12
Life Science Industry Market Research
gene2drug.com 13
Report Scope
Life Science Industry Market Research
gene2drug.com
Objectives
Understand current sources of funding
Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets
Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables
Take the pulse of the life science community regarding funding and the future of life science research
14
Life Science Industry Market Research
gene2drug.com
Framework
Secondary research
An extensive review of relevant research councils, funding agencies and private funding sources
United States and Europe
Primary research
Quantitative survey administered to life scientists in the United States, Europe and Asia
Have budget authority
Sample size ≅ 1,000
75% academic/gov’t and 25% life science industry
15
Life Science Industry Market Research
gene2drug.com
Questionnaire
Funding & Budgets
• Current sources of funding
• Average lab budgets (2013 and 2014)
• Average lab budgets for instrumentation
• Average lab budgets for consumables
• Percent budget allocation for overhead and salaries
• Laboratory headcount
Techniques
• Current usage
• Explore adoption of new products/techniques in the next 12 months
• Purchase of instrumentation (actual in 2013 and expected in 2014)
• Identify new and emerging technologies
16
Life Science Industry Market Research
gene2drug.com
Customer Sentiment
17
Will my project be
funded next year?
Life Science Industry Market Research
gene2drug.com
Product Categories
Instrumentation for…
• Cell-based analysis (flow cytometers, high content analyzers, all microscopes, high throughput screening and analysis systems, etc.)
• Genome analysis (thermal cyclers, real-time PCR instrumentation, microarray instrumentation, NGS, capillary electrophoresis, etc.)
• Protein analysis (chromatography, electrophoresis, mass spectrometry, label-free detection, calorimetry, NMR, CD, etc.)
Consumables
• Cell-based analysis kits and reagents (cell culture media and reagents, antibodies, cell biology kits, etc.)
• Genome analysis kits and reagents (enzymes, kits, ladders, nucleic acid purification and separation products, oligonucleotides [primers, RNAi], etc.)
• Protein purification and separation kits and reagents (chromatography media, electrophoresis matrices, protein ladders, etc.)
• General laboratory chemicals, plasticware, glassware and disposables
18
Life Science Industry Market Research
gene2drug.com
Cell-Based Techniques
Bacteria Culture Cell-Based Assays Confocal Microscopy Eukaryotic Cell/Tissue Culture Flow Cytometry Fluorescence Microscopy Gene Expression Analysis High Content Screening High-Throughput Screening
(HTS) Immunohistochemistry Light Microscopy Stem Cell Culture/Analysis
19
Life Science Industry Market Research
gene2drug.com
Genomics Techniques
Classical End-Point PCR Cloning/Molecular biology
Techniques DNA/RNA Microarrays Genotyping Next Generation Sequencing Real-Time PCR RNAi (including siRNA, miRNA) Sanger DNA Sequencing Single Nucleotide
Polymorphism
20
Life Science Industry Market Research
gene2drug.com
Protein Techniques
2-D Gel Electrophoresis Calorimetry (including ITC, DSC) Enzyme-linked Immunosorbent
Assay (ELISA) Label-Free Detection/Analysis
(Including Biosensors, SPR, etc.) Light Scattering (MALS, DLS) Mass Spectrometry Multiplex Bead Assays Protein Purification & Separation Protein Structural Analysis (NMR,
CD, etc.) Western Blotting
21
Life Science Industry Market Research
gene2drug.com 22
Deliverable
Life Science Industry Market Research
gene2drug.com 23
Why this report?
Life Science Industry Market Research
gene2drug.com
Share Gain/Share Protect Strategies
Where is the growth?
Funding trends?
Are researchers pitching their grants to follow the money?
24
Life Science Industry Market Research
gene2drug.com
How You Can Use It
Check assumptions
Make decisions
Forecast revenues
Identify potential growth
25
Life Science Industry Market Research
gene2drug.com
Pricing
26
Cost of non-sponsor report purchase is $18,000
• Electronic PDF of Report• Data Set in XLS Format• Data Legend
Deliverables Include:
Life Science Industry Market Research
gene2drug.com 27
Questions?
Life Science Industry Market Research
gene2drug.com
Contact
Robin Rothrock, Ph.D.Director of Publications703.778.3080 [email protected]
28
Lab Budgets and Sources of Funding in 2014
December 2013
CALL TODAY to GET YOUR COPY OF THE REPORT!
Angela FernandezMarketing Coordinator703.778.3080 [email protected]
